A new Medicare model designed to reduce Part B drug costs and improve patient quality of care is being tested in various markets around the U.S. — but will it work?
A new Medicare model designed to reduce Part B drug costs and improve patient quality of care is being tested in various markets around the U.S. — but will it work?